The Demo Site

XI'AN, CHINA, July 9 /Xinhua-PRNewswire-FirstCall/ -- Skystar Bio-Pharmaceutical Co., Ltd. ("Skystar"), a leading bio-pharmaceutical company in the People's Republic of China ("PRC"), today announced that it has successfully developed over 20 new products for livestock and aquatic animals with the drug-resistant microorganism lactobacillus acidophilus ("L. acidophilus"). The launch of these new products is expected to add over $550,000 to the company's annual revenue.

L. acidophilus is a commonly used probiotic, or "friendly" bacteria that protects against the entrance and proliferation of disease-causing organisms. The new products, developed with L. acidophilus, have a high activity of microbial strains, strong drug resistance and outstanding stability. In particular, two of the products include a highly active microorganism density of Condensed Tianji 888 and Condensed Tianji 999, which are produced using freeze-dry technology and contain as much as 10 billion CFU per gram of L. acidophilus. Skystar will launch the L. acidophilus microorganisms for both aquaculture and livestock by the end of third quarter in 2007 after gaining production approval from the Ministry of Agriculture.

Notably, the new microorganisms inaugurated Skystar's product line for use in aquaculture. Fish farming is increasingly replacing commercial fishing operations which have caused widespread overfishing resulting in strong demand for aquatic forage and feed additive products. Demand in China for microorganisms used in aquaculture is estimated to be 100,000 metric tons in 2007.
Click here to continue a Full Article

Source: CNN.com